ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ALA Arovella Therapeutics Ltd

0.1675
0.0025 (1.52%)
Mar 01 2024 - Closed
Delayed by 20 minutes

Arovella Therapeutics Financial Summary

The current ALA market cap is 153.84M. The company's latest EPS is AUD -0.0111 and P/E is -15.32.

Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 1.25M676k1.16M296k1.45M
Operating Income -8.63M-10.61M-4.81M-8.43M-10.19M
Net Income -7.8M-9.94M-5.05M-8.62M-10.18M
Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 16.25M6.71M10.69M9.21M5.47M
Total Liabilities 2.28M2.57M1.71M1.6M1.69M
Total Equity 13.98M4.14M8.98M7.62M3.78M

Cash Flow

Year End June 29 2023 20192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating -2.5M-2.88M-3.55M-6.27M-6.4M
Investing -1.38M-388k-514k-566k95k
Financing 8.1M-64k9.8M6.19M5.41M
Market Cap 153.84M
Price to Earnings Ratio -15.32
Price to Sales Ratio 106.25
Price to Cash Ratio 30.36
Price to Book Ratio 41.3
Dividend Yield -

Share Statistics

Shares Outstanding 918.42M
Average Volume (1 week) 1.61M
Average Volume (1 Month) 2.11M
52 Week Change 458.33%
52 Week High 0.185
52 Week Low 0.029
Spread (Intraday) 0.01 (2.94%)

Company Info

Company Name Arovella Therapeutics Ltd
Address level 3
melbourne, victoria 3053
Website https://www.sudapharma.com
Industry surgical,med instr,apparatus (3841)

Your Recent History

Delayed Upgrade Clock